XML 19 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Total net sales $ 4,251,000,000 $ 3,342,000,000 $ 4,029,000,000
Cost of products sold 1,890,000,000 1,685,000,000 1,864,000,000
Gross profit 2,361,000,000 1,657,000,000 2,165,000,000
Selling, general and administrative expenses 1,551,000,000 1,312,000,000 1,580,000,000
Research and development expenses 171,000,000 123,000,000 143,000,000
Goodwill impairment 0 157,000,000 0
Restructuring and other costs 17,000,000 77,000,000 81,000,000
Operating income (loss) 622,000,000 (12,000,000) 361,000,000
Other income and expenses:      
Interest expense, net 55,000,000 47,000,000 28,000,000
Other expense (income), net 8,000,000 1,000,000 (12,000,000)
Income (loss) before income taxes 559,000,000 (60,000,000) 345,000,000
Provision for income taxes 138,000,000 23,000,000 82,000,000
Net income (loss) 421,000,000 (83,000,000) 263,000,000
Less: Net income (loss) attributable to noncontrolling interests 0 0 0
Net income (loss) attributable to Dentsply Sirona $ 421,000,000 $ (83,000,000) $ 263,000,000
Net income (loss) per common share attributable to Dentsply Sirona:      
Basic (in dollars per share) $ 1.93 $ (0.38) $ 1.18
Diluted (in dollars per share) $ 1.91 $ (0.38) $ 1.17
Weighted average common shares outstanding:      
Basic (in shares) 218.4 219.2 223.1
Diluted (in shares) 220.2 219.2 224.4